新诺威频繁收购大股东资产 并购后遗症显现

远见资本局
Feb 12, 2025

出品|远见资本局作者|远见君新诺威频繁并购控股股东资产,是资产注入曲线上市?还是转型生物医药?近年来,新诺威与大股东石药集团之间频繁资产腾挪,引发关注。—01—巨资收购大股东资产投资并购是医药企业做大做强的常用手段,不过新诺威的并购有些特殊,其收购的资产几乎都来自大股东石药集团。在2024年1月耗资18.71亿元取得了巨石生物51%的股权后,新诺威目前正在推进对石药集团子公司石药百克的收购。根据...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10